Our Firm is looking forward to the start of this bellwether trial, as it will mark an important milestone in the federal vaginal mesh litigation. The outcome may provide valuable insight into how juries will rule in similar transvaginal mesh lawsuits.
New York, New York (PRWEB) November 12, 2013
As thousands of transvaginal mesh lawsuit (http://www.vaginalmeshlawsuit2015.com/) claims move forward in courts throughout the U.S., Bernstein Liebhard LLP notes that the final trial in the first round of federal bellwether cases involving C.R. Bard, Inc.’s Avaulta mesh products is scheduled to begin on December 3, 2013 in U.S. District Court, Southern District of West Virginia. According to court documents, the vaginal mesh lawsuit set for trial is one of more than 5,400 that have been filed against C.R. Bard in the federal multidistrict litigation underway in West Virginia. (In re C.R. Bard Inc. Pelvic Repair System Products Liability Litigation, MDL No. 2187)
“Our Firm is looking forward to the start of this bellwether trial, as it will mark an important milestone in the federal vaginal mesh litigation. The outcome may provide valuable insight into how juries will rule in similar transvaginal mesh lawsuits,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. Firm partner Jeffrey S. Grand, is a member of the Plaintiffs’ Steering Committee in the federal C.R. Bard litigation. Bernstein Liebhard LLP continues to offer free legal evaluations to women who allegedly suffered mesh erosion, chronic pain, infections, and other complications following implantation of devices manufactured by C.R. Bard, Inc., as well as American Medical Systems, Inc., Ethicon, Inc. and Boston Scientific Corp.
Vaginal Mesh Lawsuits
According to court documents, all of the claims pending against C.R. Bard in the Southern District of West Virginia involve similar allegations that the company’s Avaulta pelvic mesh products, which are used to treat pelvic organ prolapse and stress urinary incontinence, were defectively designed and manufactured. C.R. Bard is also accused of failing to provide doctors and patients with adequate warnings regarding the risks associated with the devices.
Court filings indicate that the first federal bellwether trial of a C.R. Bard transvaginal mesh lawsuit ended in August with an award of $2 million in compensatory and punitive damages for the Plaintiff. That case was filed on behalf of a woman who was forced to undergo multiple corrective procedures after she began suffering pain, bleeding and bladder spasms after receiving the Avaulta Plus device in 2009. Among other things, she alleged that C.R. Bard officials were aware that a certain type of plastic resin used in Avaulta products was unfit for permanent implantation in humans. (Cisson v. C.R. Bard Inc., 11-cv-00195, U.S. District Court, Southern District of West Virginia (Charleston))
The case was the second loss at trial for C.R. Bard. In July 2012, court records show that the company was ordered to pay $3.6 million of a $.5.5 million judgment after a California Superior Court jury found that C.R. Bard was partly liable for the complications suffered by another Avaulta Plus recipient. The surgeon who implanted the device was assessed the remaining portion of the judgment. (Scott v. Kannappan, S-1500-CV-266034-WDE, Superior Court for Kern County, California (Bakersfield))
Along with the federal multidistrict litigation for claims involving C.R. Bard, court filings indicate that five other consolidated proceedings involving vaginal mesh lawsuits have been established for claims naming other manufacturers as defendants. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving on the Plaintiffs’ Steering Committees for the following federal litigations: In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; and In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation - MDL No. 2327.
Mr. Grand was also named Co-Liaison Counsel in two consolidated proceedings established for C.R. Bard and Ethicon mesh lawsuits in New Jersey’s Atlantic Superior Court. He was also a member of the trial team on the first Ethicon trial, which ended in March with an $11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10).
Women who were allegedly injured by transvaginal mesh devices may be entitled to compensation for their injury-related damages, including medical expenses, lost wages, and pain and suffering. Learn More about filing a vaginal mesh lawsuit at Bernstein Liebhard LLP’s website, or visit the Firm’s Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #
Felecia L. Stern, Esq.
Bernstein Liebhard LLP